— · biotech · cancer · oncology
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series C · Apr 2026 · $56M
IP Group, M Ventures, Taiho Ventures, Fast Track Initiative, Pfizer Ventures, UTokyo Innovation Platform
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.